Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 3620-3624, July 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imamura, H.
Right arrow Articles by Aikou, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imamura, H.
Right arrow Articles by Aikou, T.

A Modified Invasion-3-(4,5-Dimethylthiazole-2-yl)-2,5-diphenyltetrazolium Bromide Assay for Quantitating Tumor Cell Invasion1

Hiroshi Imamura, Sonshin Takao2 and Takashi Aikou

The First Department of Surgery, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890, Japan

Reconstituted basement membrane matrix (Matrigel) has been utilized for in vitro assay of tumor cell invasion in recent years. In the conventional chamber for the invasion assay, however, a large number of cells passed easily through the center of the Matrigel-coated filter because the Matrigel layer could not be completely uniform by the meniscus formation. To prevent the meniscus phenomenon of the Matrigel layer, we devised a water-repellent treatment of the inside wall of the assay chamber with paraffin. Consequently, very few erythrocytes passed through the Matrigel-coated filter of this modified chamber with the erythrocyte assay, which was used to demonstrate the evenness and uniformity of the Matrigel layer on the filter. For quantitating a small number of cells which invaded through the Matrigel-coated filter by the invasion assay, a tetrazolium-based colorimetric 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide) assay was used. The invasive abilities of the eight different cells were determined by this invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay using the modified chamber with a filter coated with 70 µI of the 0.2-mg/ml Matrigel. After 72 h of incubation, the malignant cell lines significantly exceeded the normal cell lines in the percentage of invasion (P < 0.01). Therefore, the modified invasion-3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide assay provides a simple, easily reproducible in vitro assay for quantitating tumor cell invasion.

1 This study was supported in part by a Grant-in-Aid for Scientific Research and for Cancer Research from the Ministry of Education, Science and Culture of Japan.

2 Present address: Department of Surgery, The Johns Hopkins University School of Medicine, Ross Building Room 754, 720 Rutland Avenue, Baltimore, Maryland 21205. To whom requests for reprints should be addressed, at First Department of Surgery, Kagoshima University School of Medicine, 8-35-1 Sakuragaoka, Kagoshima 890, Japan.

Received 2/ 8/94. Accepted 5/ 4/94.




This article has been cited by other articles:


Home page
Int ImmunolHome page
M. Blank, L. Anafi, G. Zandman-Goddard, I. Krause, S. Goldman, E. Shalev, R. Cervera, J. Font, M. Fridkin, H.-J. Thiesen, et al.
The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model
Int. Immunol., July 1, 2007; 19(7): 857 - 865.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
X. Zhang, K. E. Green, C. Yallampalli, and Y. L. Dong
Adrenomedullin Enhances Invasion by Trophoblast Cell Lines
Biol Reprod, October 1, 2005; 73(4): 619 - 626.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. A. Stronach, G. C. Sellar, C. Blenkiron, G. J. Rabiasz, K. J. Taylor, E. P. Miller, C. E. Massie, A. Al-Nafussi, J. F. Smyth, D. J. Porteous, et al.
Identification of Clinically Relevant Genes on Chromosome 11 in a Functional Model of Ovarian Cancer Tumor Suppression
Cancer Res., December 15, 2003; 63(24): 8648 - 8655.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Q. Cao, K. M. Mak, and C. S. Lieber
DLPC decreases TGF-beta 1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells
Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1051 - G1061.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. S. Gho, W.-H. Yoon, and C.-B. Chae
Antiplasmin Activity of a Peptide That Binds to the Receptor-binding Site of Angiogenin
J. Biol. Chem., March 15, 2002; 277(12): 9690 - 9694.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. C. Sellar, L. Li, K. P. Watt, B. D. Nelkin, G. J. Rabiasz, E. A. Stronach, E. P. Miller, D. J. Porteous, J. F. Smyth, and H. Gabra
BARX2 Induces Cadherin 6 Expression and Is a Functional Suppressor of Ovarian Cancer Progression
Cancer Res., October 1, 2001; 61(19): 6977 - 6981.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Denkert, M. Köbel, S. Berger, A. Siegert, A. Leclere, U. Trefzer, and S. Hauptmann
Expression of Cyclooxygenase 2 in Human Malignant Melanoma
Cancer Res., January 1, 2001; 61(1): 303 - 308.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.